Literature DB >> 22229564

Phenotypes and enviromental factors: their influence in PCOS.

Evanthia Diamanti-Kandarakis1, Charikleia Christakou, Evangelos Marinakis.   

Abstract

Polycystic ovary syndrome (PCOS) is a complex syndrome of unclear etiopathogenesis characterized by heterogeneity in phenotypic manifestations. The clinical phenotype of PCOS includes reproductive and hormonal aberrations, namely anovulation and hyperandrogenism, which coexist with metabolic disturbances. Reflecting the crosstalk between the reproductive system and metabolic tissues, obesity not only deteriorates the metabolic profile but also aggravates ovulatory dysfunction and hyperandrogenism. Although the pathogenesis of PCOS remains unclear, the syndrome appears to involve environmental and genetic components. Starting from early life and extending throughout lifecycle, environmental insults may affect susceptible women who finally demonstrate the clinical phenotype of PCOS. Diet emerges as the major environmental determinant of PCOS. Overnutrition leading to obesity is widely recognized to have an aggravating impact, while another detrimental dietary factor may be the high content of food in advanced glycated end products (AGEs). Environmental exposure to industrial products, particularly Bisphenol A (BPA), may also exacerbate the clinical course of PCOS. AGEs and BPA may act as endocrine disruptors in the pathogenesis of the syndrome. PCOS appears to mirror the harmful influence of the modern environment on the reproductive and metabolic balance of inherently predisposed individuals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22229564     DOI: 10.2174/138161212799040457

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  20 in total

1.  Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.

Authors:  Sarantis Livadas; Christos Pappas; Athanasios Karachalios; Evangelos Marinakis; Nikoleta Tolia; Maria Drakou; Philippos Kaldrymides; Dimitrios Panidis; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2014-04-22       Impact factor: 3.633

Review 2.  Fetal programming of polycystic ovary syndrome.

Authors:  Esra Bahar Gur; Muammer Karadeniz; Guluzar Arzu Turan
Journal:  World J Diabetes       Date:  2015-07-10

3.  Advanced glycation end products interfere in luteinizing hormone and follicle stimulating hormone signaling in human granulosa KGN cells.

Authors:  Eleni A Kandaraki; Antonios Chatzigeorgiou; Efstathia Papageorgiou; Christina Piperi; Christos Adamopoulos; Athanasios G Papavassiliou; Michael Koutsilieris; Evanthia Diamanti-Kandarakis
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-15

Review 4.  Industrial endocrine disruptors and polycystic ovary syndrome.

Authors:  E Palioura; E Diamanti-Kandarakis
Journal:  J Endocrinol Invest       Date:  2013-12       Impact factor: 4.256

Review 5.  Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Authors:  Carly E Kelley; Ann J Brown; Anna Mae Diehl; Tracy L Setji
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

6.  Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.

Authors:  Thomas S Paterakis; Evanthia Diamanti-Kandarakis
Journal:  Curr Obes Rep       Date:  2014-12

Review 7.  Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact on fertility.

Authors:  Georgios Boutzios; Maria Karalaki; Evangelia Zapanti
Journal:  Endocrine       Date:  2012-08-29       Impact factor: 3.633

Review 8.  Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role?

Authors:  Emily S Barrett; Marissa Sobolewski
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

Review 9.  A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).

Authors:  Sana Siddiqui; Somaiya Mateen; Rizwan Ahmad; Shagufta Moin
Journal:  J Assist Reprod Genet       Date:  2022-10-03       Impact factor: 3.357

10.  Soy but not bisphenol A (BPA) induces hallmarks of polycystic ovary syndrome (PCOS) and related metabolic co-morbidities in rats.

Authors:  Heather B Patisaul; Natalie Mabrey; Heather B Adewale; Alana W Sullivan
Journal:  Reprod Toxicol       Date:  2014-09-19       Impact factor: 3.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.